Sebastian Grosicki - Medical University of Silesia in Katowice/Poland

基本信息

Career Trajectory

Bio

My current scientific interests include new methods of treating patients with multiple myeloma, chronic lymphocytic leukemia, acute myeloid leukemia, lymphomas and other hematological diseases. In addition, my team investigates prognostic factors in multiple myeloma patients and the importance of diet for the results of hematological treatment.

Research Interests

Papers共 384 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Role of Lifestyle and Environmental Factors in the Pathogenesis of Multiple Myeloma

Anna Suska,Agata Tyczynska,Jan Maciej Zaucha,Anna Kopinska,Grzegorz Helbig,Miroslaw Markiewicz, Katarzyna Warzybok, Ewa Leder,Sebastian Grosicki,Boguslaw Machalinski,Bartlomiej Baumert, Michal Bator,Lidia Usnarska-Zubkiewicz,Szymon Fornagiel,Hanna Ciepluch,Anna Waszczuk-Gajda,Kamila Kruczkowska-Tarantowicz,Piotr Rzepecki,Marek Hus, Anna Morawska-Krekora,Malgorzata Razny,Grzegorz Charlinski,Anna Pula,Ewa Nita,Malgorzata Wojciechowska,Malgorzata Krawczyk-Kulis, Joanna Goldberg, Tomasz Wozny,Marek Rodzaj, Dariusz Olejarz, Marlena Gronau-Dziurkowska, Ewa Skalniak,Janusz Krzyszton, Karolina Niezabitowska,Artur Jurczyszyn

EUROPEAN JOURNAL OF HAEMATOLOGY (2025)

Cited0Views0WOSBibtex

Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)

Jeff P Sharman,Talha Munir,Sebastian Grosicki, Lindsey E Roeker,John M Burke,Christine I Chen,Norbert Grzasko, George Follows, Zoltán Mátrai,Alessandro Sanna,Lugui Qiu,Ru Feng, Vu Minh Hua,Wojciech Jurczak,Matthias Ritgen,Shuhua Yi, Francesc Bosch,Catherine C Coombs,Katherine Bao, Vishalkumar Patel, Bin Liu, Livia Compte,Ananya Guntur, Denise Y Wang, Marisa Hill, Ching, Paolo Ghia, Paul M Barr

Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2500166-JCO2500166, (2025)

Cited0Views0WOSBibtex

Pelabresib Plus Ruxolitinib for JAK Inhibitor-Naive Myelofibrosis: a Randomized Phase 3 Trial

Raajit K Rampal,Sebastian Grosicki, Dominik Chraniuk,Elisabetta Abruzzese,Prithviraj Bose,Aaron T Gerds,Alessandro M Vannucchi,Francesca Palandri,Sung-Eun Lee,Vikas Gupta,Alessandro Lucchesi, Stephen T Oh,Andrew T Kuykendall,Andrea Patriarca,Alberto Álvarez-Larrán,Ruben Mesa,Jean-Jacques Kiladjian,Moshe Talpaz,Joseph M Scandura,David Lavie, Morgan Harris, Sarah-Katharina Kays, Qing Li,Rainer Boxhammer, Barbara Brown, Anna-Maria Jegg,Claire N Harrison,John Mascarenhas

Nature medicineno. 5 (2025): 1531-1538

Cited0Views0WOSNATUREBibtex

Bortezomib, Melphalan, and Prednisone with or Without Daratumumab in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (ALCYONE): Final Analysis of an Open-Label, Randomised, Multicentre, Phase 3 Trial

Maria-Victoria Mateos,Jesus San-Miguel,Michele Cavo,Kenshi Suzuki,Andrzej Jakubowiak,Stefan Knop,Chantal Doyen, Paulo Lucio, Zsolt Nagy,Ludek Pour,Sebastian Grosicki, Andre Crepaldi,Anna Marina Liberati,Philip Campbell,Sung-Soo Yoon,Genadi Iosava,Tomoaki Fujisaki,Mamta Garg, Mai Ngo, Eva G Katz,Maria Krevvata, Kasey Bolyard, Robin Carson, Fredrik Borgsten,Meletios A Dimopoulos

The Lancet Oncologyno. 5 (2025): 596-608

Cited0Views0WOSBibtex

Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naive Patients with Myelofibrosis

John O. Mascarenhas,Sebastian Grosicki,Dominik Chraniuk,Elisabetta Abruzzese,Prithviraj Bose,Aaron T. Gerds,Alessandro M. Vannucchi,Francesca Palandri,Sung-Eun Lee,Vikas Gupta,Alessandro Lucchesi,Stephen Oh,Andrew T. Kuykendall,Andrea Patriarca,Alberto Alvarez-Larran,Ruben Mesa,Jean-Jacques Kiladjian,Moshe Talpaz, Morgan Harris, Sarah-Katharina Kays, Qing Li, Barbara Brown, Anna-Maria Jegg,Claire Harrison,Raajit Rampal

BLOOD (2024): 3178-3180

Cited0Views0Bibtex

CLL-076 Final Analysis of the RESONATE-2 Study: Up to 10 Years of Follow-Up of First-Line Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jan Burger, Paul Barr,Tadeusz Robak,Carolyn Owen,Alessandra Tedeschi, Anita Sarma,Piers E.M. Patten,Sebastian Grosicki,Helen McCarthy,Fritz Offner,Edith Szafer-Glusman,Cathy Zhou,Anita Szoke,Lynne Neumayr,James P. Dean,Paolo Ghia,Thomas J. Kipps

Clinical Lymphoma Myeloma and Leukemia (2024): S342-S343

Cited0Views0Bibtex

OA-60 the Anti-BCMA Antibody-Drug Conjugate HDP-101 with a Novel Amanitin Payload Shows Promising Initial First in Human Results in Relapsed Multiple Myeloma

Marc-Steffen Raab,Robert Orlowski,Shambavi Richard,Sebastian Grosicki,Istvan Takacs,Andras Strassz,Andreas Pahl,Michael Kulke, Thorsten Michael, Anette Last, Hajnalka Szabóki,Garrit Jentsch,Oliver Schonborn-Kellenberger,Jonathan L. Kaufman

Clinical Lymphoma Myeloma and Leukemia (2024): S38

Cited0Views0Bibtex

BRUIN CLL-321: Randomized Phase III Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab (idelar) or Bendamustine Plus Rituximab (BR) in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Jeff P. Sharman,Talha Munir,Sebastian Grosicki,Lindsey Roeker,John M. Burke,Christine I Chen,Norbert Grzasko,George Follows, Zoltán Mátrai,Alessandro Sanna, Shuhua Yi,Ru Feng, Vu Minh Hua, Jadwiga Holodja,Wojciech Jurczak, Matthias Ritgen,Lu-Gui Qiu, Francesc Bosch,Catherine C. Coombs,Katherine Bao,Vishalkumar Patel, Bin Liu, Livia Compte,Ananya Guntur, Ying (Denise) Wang,Marisa Hill, Ching,Paolo Ghia,Paul M Barr

Bloodno. Supplement 1 (2024): 886-886

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn